Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Healthcare | 2.55% |
| 3 | Financials | 2.39% |
| 4 | Consumer Discretionary | 2.14% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9526
Fidelity Metaverse ETF
FMET
$47.4M
| $297K | ﹤0.01% |
16,201
-19,703
| -55% | -$424K |
|
|
INZY
9527
DELISTED
Inozyme Pharma
INZY
| $297K | ﹤0.01% |
110,648
-10,179
| -8% | -$36.8K |
|
9528
PUT
NiSource
NI
$20.4B
| $297K | ﹤0.01% |
11,800
+1,500
| +15% | +$44.2K |
|
|
NOAH
9529
PUT
Noah Holdings
NOAH
$592M
| $297K | ﹤0.01% |
+22,500
| New | +$382K |
|
|
BCOV
9530
CALL
DELISTED
Brightcove, Inc.
BCOV
| $297K | ﹤0.01% |
+47,100
| New | +$305K |
|
|
CCV
9531
PUT
DELISTED
Churchill Capital Corp V
CCV
| $297K | ﹤0.01% |
30,000
-9,400
| -24% | -$92.8K |
|
9532
iShares Core Conservative Allocation ETF
AOK
$794M
| $296K | ﹤0.01% |
9,062
-42,476
| -82% | -$1.47M |
|
9533
CALL
Carpenter Technology
CRS
$27B
| $296K | ﹤0.01% |
9,500
-3,000
| -24% | -$99.2K |
|
9534
Daktronics
DAKT
$986M
| $296K | ﹤0.01% |
109,389
+12,530
| +13% | +$43.1K |
|
9535
iShares MSCI Indonesia ETF
EIDO
$489M
| $296K | ﹤0.01% |
12,703
+1,423
| +13% | +$33.2K |
|
|
GMS
9536
CALL
DELISTED
GMS Inc
GMS
| $296K | ﹤0.01% |
7,400
-9,200
| -55% | -$440K |
|
9537
Innospec
IOSP
$2.31B
| $296K | ﹤0.01% |
3,457
-8,920
| -72% | -$842K |
|
9538
CALL
ProShares Ultra NASDAQ Biotechnology
BIB
$86.6M
| $295K | ﹤0.01% |
+6,200
| New | +$330K |
|
9539
Caribou Biosciences
CRBU
$169M
| $295K | ﹤0.01% |
27,931
-38,044
| -58% | -$354K |
|
9540
CALL
iShares MSCI Chile ETF
ECH
$1.04B
| $295K | ﹤0.01% |
12,300
-12,600
| -51% | -$328K |
|
9541
Regal Rexnord
RRX
$11.7B
| $295K | ﹤0.01% |
2,100
-31,339
| -94% | -$4.21M |
|
9542
Vanguard Russell 1000 ETF
VONE
$8.72B
| $295K | ﹤0.01% |
1,804
+401
| +29% | +$72.7K |
|
|
LFTR
9543
CALL
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
| $295K | ﹤0.01% |
29,500
-4,400
| -13% | -$43.8K |
|
9544
Aecom
ACM
$8.12B
| $294K | ﹤0.01% |
4,302
-60,031
| -93% | -$4.26M |
|
9545
PUT
Cemex
CX
$16B
| $294K | ﹤0.01% |
85,800
-13,900
| -14% | -$55K |
|
|
FOLD
9546
PUT
DELISTED
Amicus Therapeutics
FOLD
| $294K | ﹤0.01% |
28,200
+2,000
| +8% | +$22.3K |
|
9547
CALL
NeoGenomics
NEO
$2.05B
| $294K | ﹤0.01% |
34,100
-31,700
| -48% | -$315K |
|
9548
CALL
SEI Investments
SEIC
$12.8B
| $294K | ﹤0.01% |
6,000
+400
| +7% | +$21.8K |
|
|
SOL
9549
DELISTED
Emeren Group
SOL
| $294K | ﹤0.01% |
58,205
+35,844
| +160% | +$204K |
|
9550
West Bancorporation
WTBA
$508M
| $294K | ﹤0.01% |
14,127
+4,578
| +48% | +$110K |
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,858 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.